Inclisiran: A First-in-Class siRNA Therapy for Lowering Low-Density Lipoprotein Cholesterol

Samuel, E; Watford, M; Egolum, UO; Ombengi, DN; Ling, H; Cates, DW

Cates, DW (通讯作者),SynerGrx, 1954 Airport Rd,Suite 1212, Chamblee, GA 30341 USA.

ANNALS OF PHARMACOTHERAPY, 2023; 57 (3): 317

Abstract

Objective: To review the current pharmacology, pharmacokinetics/pharmacodynamics, safety, and efficacy of inclisiran in lowering lipid levels. Data So......

Full Text Link